Consultants to the pharma and biotech industries
|
Dr Peter Richardson
is a founding partner of GrantaBio LLP, specializing in pharmacology
and in vitro biology. He was a founding member of Cambridge
Biotechnology Ltd in 2001 and served as CSO and Executive Director
until 2005. Between 2005 and 2009, he served as Managing
Director and Chief Scientific Officer of this company, while also
serving as Executive Vice President and Head of Discovery in Biovitrum
AB. Between 1989 and 2006 he served as a Lecturer and Senior
Lecturer in the Department of Pharmacology, University of Cambridge
where he pioneered research into drug discovery for Parkinson’s disease
and inflammation, as well as new gene expression technologies. Between
1994 and 2001 he was an adviser to Kyowa Hakko, Parke Davis and Pfizer.
He is the author of over 70 peer-reviewed scientific papers and remains
an Associate Lecturer at the University of Cambridge. Peter
studied Biochemistry at the University of Oxford, and was awarded a
doctorate in Clinical Biochemistry from the University of
Cambridge. |
GrantaBio LLP is registered as a Limited Liability Parntership in Cambridge, UK
Registration number: OC351051